HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
P Miossec Selected Research
P Miossec Research Topics
Disease
28
Rheumatoid Arthritis
10/2011 - 05/2000
11
Inflammation (Inflammations)
01/2021 - 06/2000
7
Necrosis
01/2018 - 11/2001
5
Myositis (Idiopathic Inflammatory Myopathies)
07/2010 - 02/2003
5
Arthritis (Polyarthritis)
08/2005 - 06/2000
3
Dermatomyositis (Dermatopolymyositis)
07/2010 - 09/2000
3
Bone Resorption
06/2001 - 01/2001
2
Polymyositis
07/2010 - 04/2003
2
Synovitis
07/2009 - 07/2008
2
Joint Diseases (Joint Disease)
07/2008 - 06/2004
2
Infections
08/2005 - 09/2000
2
Arthralgia (Joint Pain)
08/2005 - 10/2004
1
Cytokine Release Syndrome
01/2021
1
COVID-19
01/2021
1
Myocardial Infarction
01/2021
1
Autoimmune Diseases (Autoimmune Disease)
01/2020
1
Liver Cirrhosis (Hepatic Cirrhosis)
10/2019
1
Fibrosis (Cirrhosis)
10/2019
1
Hepatocellular Carcinoma (Hepatoma)
01/2018
1
Osteoarthritis
10/2009
1
Neutropenia
06/2008
1
Periodontal Diseases (Periodontal Disease)
07/2006
1
Hepatitis C
08/2005
1
Tuberculosis (Tuberculoses)
03/2005
1
Exanthema (Rash)
01/2005
1
Pain (Aches)
10/2004
1
Knee Osteoarthritis
06/2004
1
Myalgia
11/2001
1
Meningitis
11/2001
1
Aseptic Meningitis
11/2001
1
Ankylosing Spondylitis
10/2001
1
Chronic Kidney Failure (Chronic Renal Failure)
07/2001
1
Experimental Arthritis
06/2000
Drug/Important Bio-Agent (IBA)
11
Cytokines
IBA
01/2021 - 05/2000
8
Interleukin-17 (Interleukin 17)
IBA
10/2019 - 06/2000
6
Infliximab (Remicade)
FDA Link
08/2009 - 11/2001
5
Interleukin-1 (Interleukin 1)
IBA
01/2021 - 06/2001
5
Biomarkers (Surrogate Marker)
IBA
10/2011 - 03/2009
5
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
09/2005 - 06/2001
4
Interleukins
IBA
01/2020 - 09/2005
4
Epitopes
IBA
09/2006 - 10/2001
3
Interleukin-6 (Interleukin 6)
IBA
01/2018 - 08/2002
3
Proteins (Proteins, Gene)
FDA Link
10/2009 - 08/2002
3
Biological Products
IBA
08/2009 - 08/2005
3
Chemokines
IBA
03/2009 - 11/2001
3
Interleukin-4 (Interleukin 4)
IBA
03/2005 - 06/2000
3
Pharmaceutical Preparations
IBA
01/2005 - 11/2001
2
Collagen Type III (Type III Collagen)
IBA
10/2009 - 03/2009
2
HLA-DR Antigens (HLA-DR)
IBA
07/2006 - 10/2001
2
Methotrexate (Mexate)
FDA Link
Generic
08/2005 - 10/2004
2
Collagen
IBA
06/2004 - 08/2002
2
DNA (Deoxyribonucleic Acid)
IBA
02/2003 - 09/2000
2
Interleukin-1 Receptors (Interleukin 1 Receptor)
IBA
08/2002 - 06/2001
2
Collagen Type I (Type I Collagen)
IBA
08/2002 - 06/2000
1
Toll-Like Receptor 7
IBA
07/2010
1
Toll-Like Receptor 3
IBA
07/2010
1
Nitric Oxide (Nitrogen Monoxide)
FDA Link
10/2009
1
Tyrosine (L-Tyrosine)
FDA Link
10/2009
1
Nucleic Acids
IBA
09/2009
1
Platelet Factor 4
IBA
08/2009
1
Apolipoprotein A-I (Apolipoprotein A1)
IBA
08/2009
1
collagen type I trimeric cross-linked peptide
IBA
03/2009
1
Iron
IBA
07/2008
1
Rituximab (Mabthera)
FDA Link
06/2008
1
Transaminases (Aminotransferases)
IBA
01/2007
1
Etanercept (Enbrel)
FDA Link
01/2007
1
HLA-DRB1 Chains (HLA DRB1)
IBA
09/2006
1
NF-kappa B (NF-kB)
IBA
09/2005
1
Rheumatoid Factor
IBA
08/2005
1
Interferons
IBA
08/2005
1
Antinuclear Antibodies
IBA
08/2005
1
Complement System Proteins (Complement)
IBA
08/2005
1
Cryoglobulins
IBA
08/2005
1
Interferon-gamma (Interferon, gamma)
IBA
03/2005
1
Transcription Factors (Transcription Factor)
IBA
03/2005
1
Interleukin-12 (IL 12)
IBA
03/2005
1
Leflunomide (Arava)
FDA Link
Generic
01/2005
1
Procollagen
IBA
06/2004
1
Interleukin-1beta (Interleukin 1 beta)
IBA
04/2003
1
factor A
IBA
11/2001
1
Antibodies
IBA
11/2001
1
HLA-B27 Antigen (HLA B27 Antigen)
IBA
10/2001
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
07/2001
1
Chemokine Receptors
IBA
07/2001
1
AA amyloidosis
IBA
07/2001
1
Interleukin 1 Receptor Antagonist Protein (Anakinra)
FDA Link
06/2001
1
Interleukin-4 Receptors (Interleukin 4 Receptor)
IBA
10/2000
1
GTP-Binding Proteins (G-Protein)
IBA
09/2000
1
RANK Ligand
IBA
06/2000
1
Tartrate-Resistant Acid Phosphatase
IBA
06/2000
Therapy/Procedure
4
Therapeutics
01/2020 - 06/2001
1
Occupational Therapy (Therapy, Occupational)
03/2009
1
Intramuscular Injections
10/2004
1
Oral Administration
10/2004